Immune to Cancer: The CRI Blog
-
Homesick Shows the Small Moments in Life with Cancer and Fundraises for Lifesaving Research
Behind-the-scenes of a new based-on-a-true-story comedy web series, “Homesick,” about an American living in London with a…
-
Durvalumab Becomes First Immunotherapy Approved for Stage III Lung Cancer
Immunotherapy tripled the median progression-free survival rate among lung cancer patients compared to those who received only…
-
Recap of the Fourth Annual Immuno-Oncology 360° Conference
The Fourth Annual Immuno-Oncology 360° Conference focused on comprehensive strategies for advancing immunotherapy, and was held from February…
-
Partner Spotlight: Thomas Hudson, Abbvie
We introduce you to Thomas Hudson, MD, vice president, head of oncology discovery and early development at…
-
Immuno-Oncology 360°: Taking Immunotherapy to the Next Level
By bringing together diverse stakeholders, IO360 hopes to facilitate the collaborations that will advance immunotherapy.
-
How Man’s Best Friend Could Help Us Cure Cancer
Cancer very is similar in dogs and humans, and scientists are now exploring how cures for one…
-
Immunotherapy is Here to Stay: Looking Back at this Year’s Breakthroughs
Important immunotherapy breakthroughs benefited patients immensely in 2017 and paved the way for even more advances in…
-
Recent FDA Announcements Herald Advances in Personalized Approaches Against Cancer
Two tumor-profiling tests recently authorized by the FDA enable doctors to tailor their treatments more effectively to…
-
Immunotherapy Shines at ASH and ESMO IO Conferences
Two conferences, one in America and one in Europe, highlight immunotherapy's continued progress and the important contributions…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.